Clinical Trial Update: Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides

View source ↗

Summary

A Phase 2 study evaluating total skin electron beam therapy (12 Gy) for stage IB-IIIA mycosis fungoides has been terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Non-hodgkin Lymphoma
• Peripheral T-cell Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Mycosis Fungoides, Lymphomas: Non-Hodgkin | Status: TERMINATED | Results posted: 2017-04-04